Massachusetts Lawmakers Prioritize Health Policy
Katherine O'Malley
August 12, 2026
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
Massachusetts lawmakers made health policy their central focus of the 2025-2026 legislative session.
There’s a new manuscript in Health Affairs on the higher fees paid to US physicians compared to other countries. Let’s work through the abstract: Higher
On Tuesday, I posted on 3 studies in The Lancet on 9/11 health issues from survivors at the WTC. Quick summary: 9/11 rescue and recovery workers
I have written about my worries that exclusion criteria for randomized control trials (RCT) limit their representativeness. Similarly, I have been worried about the “optics”
The House Ways and Means Committee has some deficit-cutting suggestions for the supercommittee. At the end of this post I add up what they’re proposing
America’s broken health system: number of underinsured up and health costs consuming nearly all income gains. Rich Daly (Modern Healthcare) reports that a new study in
There are around 19 million disabled persons between the ages of 18 and 64 in the U.S. (6.4% of all persons in this age range),
This is a follow up to my first post on the recent paper on competitive bidding in Medicare by Coulam, Feldman, and Dowd. I presume
I normally don’t try and weigh in on politics here (follow @aaronecarroll on Twitter for that), but some brief thoughts. Who would have thought being
CMS: HHS to step up enforcement of equal visitation rights for same-sex couples
A battle is heating up between public health advocates and corporations that use the First Amendment as a legal defense. I’ve posted on this before
Yesterday, I posted on 3 studies in The Lancet on 9/11 health issues from survivors at the WTC. Quick summary: 9/11 rescue and recovery workers and other WTC-exposed people
Delayed due to inexplicable technical problems, here it is: HHS inspector general says we’re wasting money on macular degeneration drugs, report Alicia Mundy and Jennifer